Sugimasa Y - Search Results

1

Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.

Morinaga S, Nakamura Y, Ishiwa N, Yoshikawa T, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S. Morinaga S, et al. Among authors: sugimasa y. Oncol Rep. 2004 Dec;12(6):1189-94. Oncol Rep. 2004. PMID: 15547736

2

Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma.

Morinaga S, Yamamoto Y, Noguchi Y, Imada T, Rino Y, Akaike M, Sugimasa Y, Takemiya S, Kameda Y, Takanashi Y. Morinaga S, et al. Among authors: sugimasa y. J Gastroenterol Hepatol. 2002 Oct;17(10):1110-6. doi: 10.1046/j.1440-1746.2002.02836.x. J Gastroenterol Hepatol. 2002. PMID: 12201873

3

Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver.

Morinaga S, Yamamoto Y, Noguchi Y, Imada T, Rino Y, Akaike M, Sugimasa Y, Takemiya S, Takanashi Y. Morinaga S, et al. Among authors: sugimasa y. Hepatogastroenterology. 2003 Sep-Oct;50(53):1521-6. Hepatogastroenterology. 2003. PMID: 14571777

4

Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.

Morinaga S, Ishiwa N, Noguchi Y, Yamamoto Y, Rino Y, Imada T, Takanashi Y, Akaike M, Sugimasa Y, Takemiya S. Morinaga S, et al. Among authors: sugimasa y. J Surg Oncol. 2005 Dec 15;92(4):331-6. doi: 10.1002/jso.20309. J Surg Oncol. 2005. PMID: 16299800

5

Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.

Saeki H, Yanoma S, Takemiya S, Sugimasa Y, Akaike M, Yukawa N, Rino Y, Imada T. Saeki H, et al. Among authors: sugimasa y. Oncol Rep. 2007 Aug;18(2):433-9. Oncol Rep. 2007. PMID: 17611667

6

Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Rino Y, Masuda M, Imada T. Yukawa N, et al. Among authors: sugimasa y. Oncology. 2007;72(3-4):205-8. doi: 10.1159/000112827. Epub 2007 Dec 21. Oncology. 2007. PMID: 18160809

7

Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry.

Morinaga S, Imada T, Shimizu A, Akaike M, Sugimasa Y, Takemiya S, Takanashi Y. Morinaga S, et al. Among authors: sugimasa y. Hepatogastroenterology. 2001 Jan-Feb;48(37):224-8. Hepatogastroenterology. 2001. PMID: 11268971

8

Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Imada T, Noguchi Y. Yukawa N, et al. Among authors: sugimasa y. Anticancer Res. 2004 May-Jun;24(3b):2101-5. Anticancer Res. 2004. PMID: 15274408 Free article.

9

[A case of flat elevated type carcinoma in adenoma of the duodenum with gastric cancer].

Tsuchida K, Morinaga S, Sugano N, Shiozawa M, Akaike M, Sugimasa Y, Takemiya S, Hayashi H, Rino Y, Imada T. Tsuchida K, et al. Among authors: sugimasa y. Gan To Kagaku Ryoho. 2006 Nov;33(12):1878-80. Gan To Kagaku Ryoho. 2006. PMID: 17212134 Review. Japanese.

10

Clinicopathological features of skip metastasis in colorectal cancer.

Shiozawa M, Akaike M, Yamada R, Godai T, Yamamoto N, Saito H, Sugimasa Y, Takemiya S, Rino Y, Imada T. Shiozawa M, et al. Among authors: sugimasa y. Hepatogastroenterology. 2007 Jan-Feb;54(73):81-4. Hepatogastroenterology. 2007. PMID: 17419236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters